Hong Kong firms to invest in Singapore biotechs with $200M fund
Aptorum Group and Aeneas Capital said Wednesday they are launching a $200 million healthcare and life science fund that could be used to invest in Singapore biotech start-ups. The companies said they also plan to make acquisitions in "identified technologies and businesses globally."
The two Hong Kong-based firms also signed a $90 million agreement Wednesday with Accelerate Technologies Pte. Ltd., the commercialization arm of Singapore’s Agency for Science, Technology and Research (A*STAR), to create up to 20 healthcare and life sciences start-ups in Singapore over the next five years. The partners said one area of focus is translation of A*STAR capabilities in medical image analytics and augmented reality into real-time MRI surgical imaging technology for use in surgical robotics...